[Ip-health] SAVE THE DATE: MSF Workshop "Controversy at customs - the detention of medicines in transit: what impact on access to medicines?" Wednesday 30 September 2009, 14:15 to 16:15 WTO building, Room A

[Alexandra HEUMBER]

This is a multipart message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
To confirm attendance, please send an email to Ms Mai Do: mdo@msf.org,=0D
You will need to register before 23 September 2009 to attend the WTO=0D
Public Forum at:=0D
https://meetings.wto.org/Forums/Registrant/SymposiumRegistration.aspx?Langu=
age=3DE=0D
=0D
=0D
INVITATION=0D
=0D
=0D
M=C3=A9decins Sans Fronti=C3=A8res workshop at the World Trade Organization=
 Public=0D
Forum=0D
=0D
Controversy at customs - the detention of medicines in transit:=0D
what impact on access to medicines?=0D
=0D
Wednesday 30 September 2009, 14:15 to 16:15=0D
WTO building, Room A=0D
=0D
=0D
Recent detainments by European Union countries=E2=80=99 customs authorities=
 of=0D
legitimate generic medicines transiting through the EU on their way to=0D
developing countries, have attracted the criticism of WTO Member States=0D
and civil society alike.  Conducted on the grounds of suspected patent or=
=0D
trademark infringements, the detentions intercept legitimate trade, and=0D
could impact the affordability and availability of generic medicines in=0D
developing countries.=0D
=0D
The incidents highlight questions about the compatibility of EC customs=0D
Regulation 1383/2003 and proposed provisions in free trade agreements with=
=0D
 WTO Member States obligations under the TRIPS Agreement,  in particular=0D
the Doha  Declaration on the TRIPS Agreement and Public Health, and  in=0D
relation to GATT.=0D
=0D
MSF will explore the legal and practical effect of  these  issues for=0D
access to medicines in developing countries, in a roundtable  with=0D
academics, member states, suppliers of  medicines, civil society=0D
organisations and representatives of the pharmaceutical industry.=0D
=0D
Introduction=0D
Chair : Michelle Childs, Policy & Advocacy Director, MSF Campaign for=0D
Access to Essential Medicines=0D
=0D
Panel of  speakers=0D
Prof Carlos Correa, University of Buenos Aires=0D
Sunjay Sudhir, Counsellor, Permanent Mission of India to WTO=0D
Sergio Balibrea, Counsellor, Delegation of the European Commission to the=
=0D
International Organisations in Geneva=0D
Amb. Dr. Tom Mboya Okeyo, Ambassador/Deputy Permanent Representative of=0D
Kenya=0D
Jos=C3=A9 Estanislau do Amaral Souza Neto, Counsellor, Permanent mission of=
=0D
Brazil to WTO=0D
=0D
Panel of respondents=0D
Arnout Gieske, Lawyer=0D
Edwin de Voogd,  Managing Director, IDA Foundation=0D
Representative of the pharmaceutical industry, tbc=0D
Niccolo Rinaldi, Member of the European Parliament=0D
Antony Taubman, Director, Intellectual Property Division, World Trade=0D
Organization=0D
=0D
Discussion & questions open to the floor=0D
=0D
To confirm attendance, please send an email to Ms Mai Do: mdo@msf.org,=0D
You will need to register before 23 September 2009 to attend the WTO=0D
Public Forum at:=0D
https://meetings.wto.org/Forums/Registrant/SymposiumRegistration.aspx?Langu=
age=3DE=0D
=0D
=0D
=0D